Baader Bank Aktiengesellschaft’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37,480
Closed -$44.6K 496
2026
Q1
$44.6K Buy
+37,480
New +$64.8K ﹤0.01% 393
2025
Q4
Sell
-34,792
Closed -$35.1K 565
2025
Q3
$35.1K Sell
34,792
-3,350
-9% -$3.71K ﹤0.01% 460
2025
Q2
$22.9K Buy
38,142
+19,876
+109% +$16.5K ﹤0.01% 412
2025
Q1
$10.2K Buy
+18,266
New +$12.6K ﹤0.01% 400
2024
Q4
Sell
-46,206
Closed -$32.8K 464
2024
Q3
$32.8K Buy
46,206
+23,656
+105% +$32.5K ﹤0.01% 402
2024
Q2
$28.5K Buy
+22,550
New +$35.1K ﹤0.01% 382

Other funds holding OCGN

Baader Bank Aktiengesellschaft's OCGN Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 37,480 shares — an estimated $44.6K sold.

Baader Bank Aktiengesellschaft first reported a position in OCGN in Q2 2024 and held it in 6 quarters. The position peaked at $44.6K in Q1 2026. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Baader Bank Aktiengesellschaft reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 37,480 Ocugen shares in Q2 2026, an estimated $44.6K.
  • Baader Bank Aktiengesellschaft first reported a position in Ocugen in Q2 2024 and held it in 6 quarters.
  • Baader Bank Aktiengesellschaft's Ocugen position peaked at $44.6K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.